An in vitro system to model the establishment and reactivation of HIV-1 latency

Journal of Immunology

Volumn 181, Issue 11, 2009, Pages 7713-7720

  Marini, Alessandra ^a   Harper, Jill M ^a   Romerio, Fabio ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CD28 ANTIGEN; CD3 ANTIGEN; INTERLEUKIN 7; MONOCLONAL ANTIBODY;

ARTICLE; BIOLOGY; CD4+ T LYMPHOCYTE; CELL ACTIVATION; CELL DEATH; CELL PROLIFERATION; CONTROLLED STUDY; DENDRITIC CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VITRO STUDY; MODEL; MORTALITY; PRIORITY JOURNAL; VIRUS LATENCY; VIRUS REACTIVATION; VIRUS REPLICATION;

EID: 71849085382     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.181.11.7713     Document Type: Article

References (50)

1. Piatak, M., Jr., M. S. Saag, L. C. Yang, S. J. Clark, J. C. Kappes, K. C. Luk, B. H. Hahn, G. M. Shaw, and J. D. Lifson. 1993. High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science 259: 1749-1754. (Pubitemid 23114661)
2. Harper, M. E., L. M. Marselle, R. C. Gallo, and F. Wong-Staal. 1986. Detection of lymphocytes expressing human T-lymphotropic virus type III in lymph nodes and peripheral blood from infected individuals by in situ hybridization. Proc. Natl. Acad. Sci. USA 83: 772-776.
3. Chun, T. W., D. Finzi, J. Margolick, K. Chadwick, D. Schwartz, and R. F. Siliciano. 1995. In vivo fate of HIV-1-infected T cells: quantitative analysis of the transition to stable latency. Nat. Med. 1: 1284-1290.
4. Finzi, D., M. Hermankova, T. Pierson, L. M. Carruth, C. Buck, R. E. Chaisson, T. C. Quinn, K. Chadwick, J. Margolick, R. Brookmeyer, et al. 1997. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science 278: 1295-1300. (Pubitemid 27495742)
5. Chun, T. W., L. Stuyver, S. B. Mizell, L. A. Ehler, J. A. Mican, M. Baseler, A. L. Lloyd, M. A. Nowak, and A. S. Fauci. 1997. Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. Proc. Natl. Acad. Sci. USA 94: 13193-13197. (Pubitemid 27518498)
6. Wong, J. K., M. Hezareh, H. F. Günthard, D. V. Havlir, C. C. Ignacio, C. A. Spina, and D. D. Richman. 1997. Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. Science 278: 1291-1295.
7. + T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy. Nat. Med. 5: 512-517.
8. Han, Y., M. Wind-Rotolo, H. C. Yang, J. D. Siliciano, and R. F. Siliciano. 2007. Experimental approaches to the study of HIV-1 latency. Nat. Rev. Microbiol. 5: 95-106. (Pubitemid 46151868)
9. Jenkins, M. K., A. Khoruts, E. Ingulli, D. L. Mueller, S. J. McSorley, R. L. Reinhardt, A. Itano, and K. A. Pape. 2001. In vivo activation of antigen-specific CD4 T cells. Annu. Rev. Immunol. 19: 23-45. (Pubitemid 32368028)
10. + T cells in protective immunity to influenza. Immunol. Rev. 211: 8-22.
11. Marrack, P., and J. Kappler. Control of T cell viability. 2004. Annu. Rev. Immunol. 22: 765-787.
12. Bradley, L. M., L. Haynes, and S. L. Swain. 2005. IL-7: maintaining T-cell memory and achieving homeostasis. Trends Immunol. 26: 172-176.
13. Khaled, A. R., and S. K. Durum. 2003. Death and baxes: mechanisms of lymphotrophic cytokines. Immunol. Rev. 193: 48-57.
14. Margolick, J. B., D. J. Volkman, T. M. Folks, and A. S. Fauci. 1987. Amplification of HTLV-III/LAV infection by antigen-induced activation of T cells and direct suppression by virus of lymphocyte blastogenic responses. J. Immunol. 138: 1719-1723.
15. Zack, J. A., A. J. Cann, J. P. Lugo, and I. S. Chen. 1988. HIV-1 production from infected peripheral blood T cells after HTLV-I induced mitogenic stimulation. Science 240: 1026-1029.
16. + T lymphocytes in vivo. J. Virol. 77: 7383-7392.
17. + T cells in vivo. J. Virol. 78: 9105-9114.
18. + T cells during primary immune responses. Proc. Natl. Acad. Sci. USA 100: 15006-15010.
19. Seddiki, N., B. Santner-Nanan, J. Martinson, J. Zaunders, S. Sasson, A. Landay, M. Solomon, W. Selby, S. I. Alexander, R. Nanan, et al. 2006. Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J. Exp. Med. 203: 1693-1700. (Pubitemid 44036275)
20. + regulatory T cells in peripheral blood are primarily of effector memory phenotype. J. Clin. Oncol. 25: 2628-2630.
21. Sallusto, F., D. Lenig, R. Foster, M. Lipp, and A. Lanzavecchia. 1999. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401: 708-712. (Pubitemid 129515761)
22. Rathmell, J. C., E. A. Farkash, W. Gao, and C. B. Thompson. 2001. IL-7 enhances the survival and maintains the size of naive T cells. J. Immunol. 167: 6869-6876.
23. Wang, F. X., Y. Xu, J. Sullivan, E. Souder, E. G. Argyris, E. A. Acheampong, J. Fisher, M. Sierra, M. M. Thomson, R. Najera, et al. 2005. IL-7 is a potent and proviral strain-specific inducer of latent HIV-1 cellular reservoirs of infected individuals on virally suppressive HAART. J. Clin. Invest. 115: 128-137.
24. Alcamí, J., T. Laín de Lera, L. Folgueira, M. A. Pedraza, J. M. Jacqué, F. Bachelerie, A. R. Noriega, R. T. Hay, D. Harrich, R. B. Gaynor, et al. 1995. Absolute dependence on κB responsive elements for initiation and Tat-mediated amplification of HIV transcription in blood CD4 T lymphocytes. EMBO J. 14: 1552-1560.
25. Pendergrast, P. S., and N. Hernandez. 1997. RNA-targeted activators, but not DNA-targeted activators, repress the synthesis of short transcripts at the human immunodeficiency virus type 1 long terminal repeat. J. Virol. 71: 910-917.
26. Lin, X., D. Irwin, S. Kanazawa, L. Huang, J. Romeo, T. S. Yen, and B. M. Peterlin. 2003. Transcriptional profiles of latent human immunodeficiency virus in infected individuals: effects of Tat on the host and reservoir. J. Virol. 77: 8227-8236. (Pubitemid 36871450)
27. Popovic, M., K. Tenner-Racz, C. Pelser, H. J. Stellbrink, J. van Lunzen, G. Lewis, V. S. Kalyanaraman, R. C. Gallo, and P. Racz. 2005. Persistence of HIV-1 structural proteins and glycoproteins in lymph nodes of patients under highly active antiretroviral therapy. Proc. Natl. Acad. Sci. USA 102: 14807-14812. (Pubitemid 41457137)
28. Brussel, A., and P. Sonigo. 2004. Evidence for gene expression by unintegrated human immunodeficiency virus type 1 DNA species. J. Virol. 78: 11263-11271. (Pubitemid 39299665)
29. Ruff, C. T., S. C. Ray, P. Kwon, R. Zinn, A. Pendleton, N. Hutton, R. Ashworth, S. Gange, T. C. Quinn, R. F. Siliciano, and D. Persaud. 2002. Persistence of wild-type virus and lack of temporal structure in the latent reservoir for human immunodeficiency virus type 1 in pediatric patients with extensive antiretroviral exposure. J. Virol. 76: 9481-9492.
30. Yeni, P. G., S. M. Hammer, C. C. Carpenter, D. A. Cooper, M. A. Fischl, J. M. Gatell, B. G. Gazzard, M. S. Hirsch, D. M. Jacobsen, D. A. Katzenstein, et al. 2002. Antiretroviral treatment for adult HIV infection in 2002: updated recommendations of the International AIDS Society-USA Panel. J. Am. Med. Assoc. 288: 222-235. (Pubitemid 34755283)
31. Romerio, F., M. N. Gabriel, and D. M. Margolis. 1997. Repression of human immunodeficiency virus type 1 through the novel cooperation of human factors YY1 and LSF. J. Virol. 71: 9375-9382. (Pubitemid 27492380)
32. Coull, J. J., F. Romerio, J. M. Sun, J. L. Volker, K. M. Galvin, J. R. Davie, Y. Shi, U. Hansen, and D. M. Margolis. 2000. The human factors YY1 and LSF repress the human immunodeficiency virus type 1 long terminal repeat via recruitment of histone deacetylase 1. J. Virol. 74: 6790-6799.
33. He, G., and D. M. Margolis. 2002. Counterregulation of chromatin deacetylation and histone deacetylase occupancy at the integrated promoter of human immunodeficiency virus type 1 (HIV-1) by the HIV-1 repressor YY1 and HIV-1 activator Tat. Mol. Cell. Biol. 22: 2965-2973. (Pubitemid 34437455)
34. + T cells using a combination of cytokines. J. Exp. Med. 188: 83-91.
35. Moriuchi, H., M. Moriuchi, and A. S. Fauci. 1999. Induction of HIV-1 replication by allogeneic stimulation. J. Immunol. 162: 7543-7548. (Pubitemid 29277735)
36. Korin, Y. D., D. G. Brooks, S. Brown, A. Korotzer, and J. A. Zack. 2002. Effects of prostratin on T-cell activation and human immunodeficiency virus latency. J. Virol. 76: 8118-8123. (Pubitemid 34809066)
37. Brooks, D. G., D. H. Hamer, P. A. Arlen, L. Gao, G. Bristol, C. M. Kitchen, E. A. Berger, and J. A. Zack. 2003. Molecular characterization, reactivation, and depletion of latent HIV. Immunity 19: 413-423.
38. + T cells in the simian immunodeficiency virus/macaque model of human immunodeficiency virus type 1 latency. J. Virol. 81: 1660-1670.
39. Folks, T. M., K. A. Clouse, J. Justement, A. Rabson, E. Duh, J. H. Kehrl, and A. S. Fauci. 1989. Tumor necrosis factor α induces expression of human immunodeficiency virus in a chronically infected T-cell clone. Proc. Natl. Acad. Sci. USA 86: 2365-2368. (Pubitemid 19102509)
40. Folks, T. M., J. Justement, A. Kinter, C. A. Dinarello, and A. S. Fauci. 1987. Cytokine-induced expression of HIV-1 in a chronically infected promonocyte cell line. Science 238: 800-802.
41. Antoni, B. A., A. B. Rabson, A. Kinter, M. Bodkin, and G. Poli. 1994. NF-κB-dependent and -independent pathways of HIV activation in a chronically infected T cell line. Virology 202: 684-694. (Pubitemid 2102829)
42. Jordan, A., D. Bisgrove, and E. Verdin. 2003. HIV reproducibly establishes a latent infection after acute infection of T cells in vitro. EMBO J. 22: 1868-1877. (Pubitemid 36460143)
43. + T cells from human immunodeficiency virus type 1 (HIV-1)-infected individuals carry integrated HIV-1 genomes within actively transcribed host genes. J. Virol. 78: 6122-6133.
44. + T cells in the absence of activating stimuli. J. Virol. 79: 14179-14188.
45. + T cells to HIV-1 infection: a novel model of HIV-1 latency. Blood 110: 4161-4164.
46. Zack, J. A., S. J. Arrigo, S. R. Weitsman, A. S. Go, A. Haislip, and I. S. Chen. 1990. HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell 61: 213-222. (Pubitemid 20149353)
47. Pierson, T. C., Y. Zhou, T. L. Kieffer, C. T. Ruff, C. Buck, and R. F. Siliciano. 2002. Molecular characterization of preintegration latency in human immunodeficiency virus type 1 infection. J. Virol. 76: 8518-8531. (Pubitemid 34864046)
48. Siliciano, J. D., and R. F. Siliciano. 2004. A long-term latent reservoir for HIV-1: discovery and clinical implications. J. Antimicrob. Chemother. 54: 6-9.
49. Gondois-Rey, F., A. Biancotto, M. Pion, A. L. Chenine, P. Gluschankof, V. Horejsi, C. Tamalet, R. Vigne, and I. Hirsch. 2001. Production of HIV-1 by resting memory T lymphocytes. AIDS 15: 1931-1940. (Pubitemid 32980634)
50. Lin, J. X., and W. J. Leonard. 2000. The role of Stat5a and Stat5b in signaling by IL-2 family cytokines. Oncogene 19: 2566-2576.